SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-005952
Filing Date
2022-02-08
Accepted
2022-02-08 17:05:16
Documents
2
Period of Report
2022-02-08

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea155102-6k_altamira.htm 6-K 18442
2 CONVERTIBLE LOAN AGREEMENT, DATED AS OF FEBRUARY 4, 2022, BY AND AMONG ALTAMIRA ea155102ex99-1_altamira.htm EX-99.1 101004
  Complete submission text file 0001213900-22-005952.txt   120795
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36582 | Film No.: 22602485
SIC: 2834 Pharmaceutical Preparations